MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT05730816
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Mesothelioma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Magnesium sulfate — DRUGIntravenous infusion of magnesium sulfate prior to intraoperative chemotherapy with cisplatin.
- Normal Saline — DRUGIntravenous infusion of normal saline.
Study Details
In this research study, investigators will test whether prophylactic high-dose IV Mg administration attenuates the risk of AKI in patients with malignant mesothelioma receiving intraoperative chemotherapy (HIOC) with cisplatin compared to placebo .
Key Dates
- Start date
- Apr 4, 2023
- Status verified
- Nov 2025
- Primary completion
- Apr 3, 2027
- Completion
- Jan 1, 2028
Study Design
- Enrollment
- 130 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Magnesium SulfateThe IV Mg will start at 1 g/hour (25 ml/hour) within one hour following induction of anesthesia and stabilization of the patient. The infusion will continue for 24 hours and serum Mg levels will be monitored every 4 hours (+/-1 hour) for 28 hours following initiation of the Mg. Dose adjustments to the Mg infusion will be made as necessary to reach target serum Mg levels (3-5 mg/dl).
- Placebo Comparator: Normal SalinePatients randomized to placebo will receive an equal volume of normal saline (0.9% NS) placebo which will be administered as a continuous infusion at 25 ml/hour. The infusion will continue for 24 hours.
Primary Outcome Measure
AUC of SCr measured daily over 7 days in Mg- versus placebo-treated patients [ Time Frame: 7 days ]
Central Contacts
- Shruti Gupta, MD, MPH617-732-6383
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02130 | Shruti Gupta David E. Leaf |
Find similar trials in Boston, MA
By research site
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic BiomarkersRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Stereotactic Magnetic Resonance Guided Radiation TherapyRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Study to Evaluate VT3989 in Patients With Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · Vivace Therapeutics, Inc · San Francisco, California